Ovarian Clear Cell Carcinoma: Genomic Characterization, Pathogenesis and Targeted Therapy

被引：2

作者：

Xie, Yunkai ^{[1
]}

Kong, Weimin ^{[1
,2
]}

Luo, Dan ^{[1
]}

Chen, Shuning ^{[1
]}

Zhao, Xiaoling ^{[1
]}

Zhang, He ^{[1
]}

机构：

[1] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Beijing Maternal & Child Hlth Care Hosp, Dept Gynecol Oncol, Beijing, Peoples R China

[2] Qi He Lou St, Beijing 100000, Peoples R China

来源：

ANTICANCER RESEARCH | 2023年 / 43卷 / 08期

关键词：

Endometriosis; ovarian clear cell carcinoma; endometriosis-associated ovarian cancer; oxidative stress; review; GLUTATHIONE-PEROXIDASE; 3; PTEN EXPRESSION; ENDOMETRIOSIS; CANCER; PROGRESSION; ADENOCARCINOMA; PROLIFERATION; INHIBITION; RESISTANCE; MUTATIONS;

D O I：

10.21873/anticanres.16515

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Ovarian clear cell carcinomas (OCCCs) are a subtype of ovarian epithelial tumors that arise from the malignant transformation of endometriosis (EMs). These tumors have distinctive molecular features, high malignant potential, low sensitivity to conventional chemotherapy, and poor prognosis. The process and mechanism of malignant transformation from EMs to OCCCs remains elusive. Elucidation of the molecular pathogenesis and drug resistance mechanism of OCCCs is essential to guide the clinical management and basic research of this disease. This paper provides a comprehensive review of the mechanisms of malignant transformation, genomic characteristics, drug resistance and targeted therapy of OCCCs. The review aims to provide new insights for the clinical management of advanced OCCCs.

引用

页码：3401 / 3410

页数：10

共 50 条

[21] Evolution of the HIF targeted therapy in clear cell renal cell carcinoma
Golijanin, Borivoj
Malshy, Kamil
Khaleel, Sari
Lagos, Galina
Amin, Ali
Cheng, Liang
Golijanin, Dragan
Mega, Anthony
CANCER TREATMENT REVIEWS, 2023, 121
[22] Genomic differences and survival in African Americans with metastatic clear cell renal cell carcinoma in the targeted therapy era.
Rose, Tracy Lynn
Krishnan, Bhavani
Kuykendal, Adam Rea
Smith, Angela
Milowsky, Matthew I.
Kim, William Y.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[23] Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing
Kim, Se Ik
Lee, Ji Won
Lee, Maria
Kim, Hee Seung
Chung, Hyun Hoon
Kim, Jae-Weon
Park, Noh Hyun
Song, Yong-Sang
Seo, Jeong-Sun
GYNECOLOGIC ONCOLOGY, 2018, 148 (02) : 375 - 382
[24] Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation
Dent, J
Hall, GD
Wilkinson, N
Perren, TJ
Richmond, I
Markham, AF
Murphy, H
Bell, S
BRITISH JOURNAL OF CANCER, 2003, 88 (10) : 1578 - 1583
[25] Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation
J Dent
G D Hall
N Wilkinson
T J Perren
I Richmond
A F Markham
H Murphy
S M Bell
British Journal of Cancer, 2003, 88 : 1578 - 1583
[26] Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.
Bi, Xiao
Zhao, Siming
Adeniran, Adebowale
Kluger, Harriet M.
Xie, Zuoquan
Nawaf, Cayce
Merino, Maria J.
Valera, Vladimir
Pantuck, Allan J.
Said, Jonathan W.
Belldegrun, Arie S.
Lifton, Richard P.
Shuch, Brian M.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[27] Re: Genomic Characterization of Sarcomatoid Transformation in Clear Cell Renal Cell Carcinoma
Atala, Anthony
JOURNAL OF UROLOGY, 2017, 197 (04): : 1002 - 1002
[28] Therapy of a patient with clear cell renal cell carcinoma with molecularly targeted drugs
Bodnar, Lubomir
ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 : C5 - C6
[29] Molecular characterization of a panel of ovarian clear cell carcinoma (OCCC) cell lines
Huang, R.
Ye, J.
Kuay, K. T.
Tan, T. Z.
Heong, V.
Tan, D. S.
ANNALS OF ONCOLOGY, 2017, 28
[30] Osteopontin is a new target molecule for ovarian clear cell carcinoma therapy
Matsuura, Motoki
Suzuki, Takahiro
Saito, Tsuyoshi
CANCER SCIENCE, 2010, 101 (08) : 1828 - 1833

← 1 2 3 4 5 →